U.S. markets open in 1 hour 58 minutes

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.9200-0.0800 (-1.60%)
At close: 04:00PM EDT
4.9200 0.00 (0.00%)
After hours: 04:47PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close5.0000
Bid0.0000 x 3200
Ask0.0000 x 1800
Day's Range4.8800 - 5.0500
52 Week Range4.7350 - 17.5000
Avg. Volume1,058,877
Market Cap635.32M
Beta (5Y Monthly)1.60
PE Ratio (TTM)7.66
EPS (TTM)0.6420
Earnings DateAug 08, 2022 - Aug 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
21% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ORGO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Organogenesis Holdings Inc.
    ORGO: Raising target price to $6.00ORGANOGENESIS HOLDINGS INC has an Investment Rating of HOLD; a target price of $6.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • TipRanks

    2 “Strong Buy” Stocks Trading at Rock-Bottom Prices

    What to do in today’s market? The last few trading sessions of declining stocks would seem to indicate that the late-May rally we saw has run its course. But that doesn’t mean the opportunities for buy-minded investors are all gone. The recent declines, and the overall downward trend we’ve seen year-to-date, have left many fundamentally sound stocks trading at rock bottom prices. And that may have created an opportunity for investors willing do a bit of bottom fishing. The trick for investors, h

  • Simply Wall St.

    Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested a year ago

    Investing in stocks comes with the risk that the share price will fall. And there's no doubt that Organogenesis...

  • Motley Fool

    Organogenesis Holdings Inc. (ORGO) Q1 2022 Earnings Call Transcript

    Good afternoon, ladies and gentlemen, and welcome to the first quarter 2022 earnings conference call for Organogenesis Holdings Inc. [Operator instructions] Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the Company's filings with the Securities and Exchange Commission, including Item 1A risk factors of the Company's most recent annual report. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made.